NCT02173639View on ClinicalTrials.gov

Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2009

Conditions
Healthy
Interventions
DRUG

BI 1356/metformin

fixed dose combination tablet

DRUG

BI 1356

DRUG

Metformin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY